1 |
Pathania S, Khan MI, Kumar A, Gupta AK, Rani K, Ramesh Parashar T, Jayaram J, Ranjan Mishra P, Srivastava A, Mathur S, Hari S, Hariprasad G. Proteomics of Sentinel Lymph Nodes in Early Breast Cancer for Identification of Thymidylate Synthase as a Potential Biomarker to Flag Metastasis: A Preliminary Study. Cancer Manag Res 2020;12:4841-54. [PMID: 32606973 DOI: 10.2147/CMAR.S255684] [Reference Citation Analysis]
|
2 |
Siddiqui A, Ceppi P. A non-proliferative role of pyrimidine metabolism in cancer. Mol Metab 2020;35:100962. [PMID: 32244187 DOI: 10.1016/j.molmet.2020.02.005] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 6.5] [Reference Citation Analysis]
|
3 |
Siddiqui A, Gollavilli PN, Schwab A, Vazakidou ME, Ersan PG, Ramakrishnan M, Pluim D, Coggins S, Saatci O, Annaratone L, Hm Schellens J, Kim B, Asangani IA, Rasheed SAK, Marchiò C, Sahin O, Ceppi P. Thymidylate synthase maintains the de-differentiated state of triple negative breast cancers. Cell Death Differ 2019;26:2223-36. [PMID: 30737477 DOI: 10.1038/s41418-019-0289-6] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 5.3] [Reference Citation Analysis]
|
4 |
Gmeiner WH. Recent Advances in Our Knowledge of mCRC Tumor Biology and Genetics: A Focus on Targeted Therapy Development. Onco Targets Ther 2021;14:2121-30. [PMID: 33790575 DOI: 10.2147/OTT.S242224] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
5 |
Kang M, Ma X, Shi J, Chen G, Jin X, Wang J, Lin L, Wu Z, Chen K, Xu J, Huang P, Chen J. Distinct molecular phenotype and the potential prognostic value of immune prognostic index and tumor infiltrating lymphocytes in hepatoid adenocarcinoma of stomach. Transl Oncol 2022;19:101380. [PMID: 35276435 DOI: 10.1016/j.tranon.2022.101380] [Reference Citation Analysis]
|